PMID- 19230429 OWN - NLM STAT- MEDLINE DCOM- 20090305 LR - 20131121 IS - 0125-2208 (Print) IS - 0125-2208 (Linking) VI - 90 Suppl 2 DP - 2007 Nov TI - Cryptococcal meningoradiculitis: an atypical presentation after initiation of antiretroviral therapy. PG - 85-8 AB - Atypical presentations of cryptococcal infection have been described as clinical manifestations of immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients following commence of antiretroviral therapy (ART). The authors describe a patient presenting with cryptococcal meningoradiculitis two weeks after initiation of ART. In patients with advanced HIV disease, immune reconstitution induced by ART can precipitate onset of atypical clinical manifestations in those patients with latent cryptococcal infection of the central nervous system. FAU - Jongwutiwes, Ubonvan AU - Jongwutiwes U AD - Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. siujw@mahidol.ac.th FAU - Malathum, Kumthorn AU - Malathum K FAU - Sungkanuparph, Somnuek AU - Sungkanuparph S LA - eng PT - Case Reports PT - Journal Article PL - Thailand TA - J Med Assoc Thai JT - Journal of the Medical Association of Thailand = Chotmaihet thangphaet JID - 7507216 RN - 0 (Anti-Bacterial Agents) RN - 0 (Anti-HIV Agents) RN - 0 (Anti-Retroviral Agents) RN - 2T8Q726O95 (Lamivudine) RN - 5E8K9I0O4U (Ciprofloxacin) RN - 75J73V1629 (Ceftriaxone) RN - 7XU7A7DROE (Amphotericin B) RN - 99DK7FVK1H (Nevirapine) RN - BO9LE4QFZF (Stavudine) SB - IM MH - Adult MH - Amphotericin B/therapeutic use MH - Anti-Bacterial Agents/therapeutic use MH - Anti-HIV Agents/*adverse effects MH - Anti-Retroviral Agents/adverse effects MH - Ceftriaxone/therapeutic use MH - Ciprofloxacin/therapeutic use MH - Female MH - HIV Infections/*physiopathology MH - Humans MH - Lamivudine/adverse effects MH - Meningitis, Cryptococcal/*chemically induced/diagnosis/etiology MH - Nevirapine/adverse effects MH - Radiculopathy/*chemically induced/diagnosis/etiology MH - Stavudine/adverse effects EDAT- 2007/11/01 00:00 MHDA- 2009/03/06 09:00 CRDT- 2009/02/24 09:00 PHST- 2009/02/24 09:00 [entrez] PHST- 2007/11/01 00:00 [pubmed] PHST- 2009/03/06 09:00 [medline] PST - ppublish SO - J Med Assoc Thai. 2007 Nov;90 Suppl 2:85-8.